Knockdown of DDX5 inhibits the proliferation and tumorigenesis in esophageal cancer

Oncology Research

Volumn 25, Issue 6, 2017, Pages 887-895

  Ma, Zhenchuan ^a   Feng, Jie ^a   Guo, Yurui ^a   Kong, Ranran ^a   Ma, Yuefeng ^a   Sun, Liangzhang ^a   Yang, Xiaoping ^a   Zhou, Bin ^a   Li, Shaomin ^a   Zhang, Wei ^a   Jiang, Jiantao ^a   Zhang, Jin ^a   Qiao, Zhe ^a   Cheng, Yao ^a   Zha, Danjie ^a   Liu, Shiyuan ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

DEAD (Asp Glu Ala Asp) box protein 5 (DDX5); Esophageal cancer (EC); Invasion; Proliferation

Indexed keywords

BETA CATENIN; CYCLIN D1; MESSENGER RNA; MYC PROTEIN; NERVE CELL ADHESION MOLECULE; RETINOIC ACID INDUCIBLE PROTEIN I; SHORT HAIRPIN RNA; UVOMORULIN; WNT PROTEIN; CTNNB1 PROTEIN, HUMAN; DDX5 PROTEIN, HUMAN; DEAD BOX PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL CANCER CELL LINE; ESOPHAGUS CANCER; ESOPHAGUS EPITHELIUM; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MIGRATION INHIBITION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; RNA INTERFERENCE; TUMOR INVASION; WNT SIGNALING PATHWAY; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; DRUG SCREENING; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENE KNOCKDOWN; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE; WNT SIGNALING;

ANIMALS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DEAD-BOX RNA HELICASES; EPITHELIAL-MESENCHYMAL TRANSITION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE, INBRED BALB C; WNT SIGNALING PATHWAY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85021724615     PISSN: 09650407     EISSN: 15553906     Source Type: Journal    
DOI: 10.3727/096504016X14817158982636     Document Type: Article

References (33)

1. Chen J, Kwong D, Cao T, Hu Q, Zhang L, Ming X, Fu L, Guan X. Esophageal squamous cell carcinoma (ESCC): Advance in genomics and molecular genetics. Dis Esophagus 2015;28:84-9.
2. Kimura M, Ishiguro H, Tanaka T, Takeyama H. Advanced esophageal cancer with tracheobronchial fistula successfully treated by esophageal bypass surgery. Int J Surg Case Rep. 2015;9:115-8.
3. Lagergren J. Oesophageal cancer in 2014: Advances in curatively intended treatment. Nature Rev Gastroenterol Hepatol. 2015;12:74-5.
4. Lin J, Kligerman S, Goel R, Sajedi P, Suntharalingam M, Chuong MD. State-of-the-art molecular imaging in esophageal cancer management: Implications for diagnosis, prognosis, and treatment. J Gastrointest Oncol. 2015;6:3-19.
5. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5-29.
6. Linder P, Jankowsky E. From unwinding to clamping-The DEAD box RNA helicase family. Nat Rev Mol Cell Biol. 2011;12:505-16.
7. Fuller-Pace FV. DExD/H box RNA helicases: Multifunctional proteins with important roles in transcriptional regulation. Nucleic Acids Res. 2006;34:4206-15.
8. Jalal C, Uhlmann-Schiffler H, Stahl H. Redundant role of DEAD box proteins p68 (Ddx5) and p72/p82 (Ddx17) in ribosome biogenesis and cell proliferation. Nucleic Acids Res. 2007;35:3590-601.
9. Caretti G, Lei EP, Sartorelli V. The DEAD-box p68/p72 proteins and the noncoding RNA steroid receptor activator SRA: Eclectic regulators of disparate biological functions. Cell Cycle 2007;6:1172-6.
10. Fuller-Pace FV, Ali S. The DEAD box RNA helicases p68 (Ddx5) and p72 (Ddx17): Novel transcriptional co-regulators. Biochem Soc Trans. 2008;36:609-12.
11. Wang H, Gao X, Yang JJ, Liu Z-R. Interaction between p68 RNA helicase and Ca2+-calmodulin promotes cell migration and metastasis. Nat Commun. 2013;4:1354-81.
12. Wang Z, Luo Z, Zhou L, Li X, Jiang T, Fu E. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating catenin signaling pathway. Cancer Sci. 2015;106:1303-12.
13. Clark EL, Coulson A, Dalgliesh C, Rajan P, Nicol SM, Fleming S, Heer R, Gaughan L, Leung HY, Elliott DJ. The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer. Cancer Res. 2008;68:7938-46.
14. Wang D, Huang J, Hu Z. RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells. Mol Cell Proteomics 2012;11:M111. 011932.
15. Mazurek A, Luo W, Krasnitz A, Hicks J, Powers RS, Stillman B. DDX5 regulates DNA replication and is required for cell proliferation in a subset of breast cancer cells. Cancer Discov. 2012;2:812-25.
16. Janknecht R. Multi-talented DEAD-box proteins and potential tumor promoters: p68 RNA helicase (DDX5) and its paralog, p72 RNA helicase (DDX17). Am J Transl Res. 2010;2:223-4.
17. Shin S, Rossow KL, Grande JP, Janknecht R. Involvement of RNA helicases p68 and p72 in colon cancer. Cancer Res. 2007;67:7572-8.
18. Li W, Jiang G, Zhou J, Wang H, Gong Z, Zhang Z, Min K, Zhu H, Tan Y. Down-regulation of MIR-140 induces EMT and promotes invasion by targeting Slug in esophageal cancer. Cell Physiol Biochem. 2014;34:1466-76.
19. Rees JR, Onwuegbusi BA, Save VE, Alderson D, Fitzgerald RC. In vivo and in vitro evidence for transforming growth factor-beta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma. Cancer Res. 2006;66:9583-90.
20. Sánchez-Tilló E, Liu Y, de Barrios O, Siles L, Fanlo L, Cuatrecasas M, Darling DS, Dean DC, Castells A, Postigo A. EMT-activating transcription factors in cancer: Beyond EMT and tumor invasiveness. Cell Mol Life Sci. 2012;69: 3429-56.
21. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metast Rev. 2009;28:15-33.
22. Yao H, Ashihara E, Maekawa T. Targeting the Wnt/ catenin signaling pathway in human cancers. Expert Opin Ther Targets 2011;15:873-87.
23. Li J, Ying J, Fan Y, Wu L, Ying Y, Chan AT, Srivastava G, Tao Q. WNT5A antagonizes WNT/catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma. Cancer Biol Ther. 2010;10:617-24.
24. Zhou C, Liu S, Zhou X, Xue L, Quan L, Lu N, Zhang G, Bai J, Wang Y, Liu Z. Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin/ TCF pathway in human esophageal squamous cell carcinoma. Int J Cancer 2005;113:891-8.
25. Ge XS, Ma HJ, Zheng XH, Ruan HL, Liao XY, Xue WQ, Chen YB, Zhang Y, Jia WH. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway. Cancer Sci. 2013;104:1675-82.
26. Polakis P. The oncogenic activation of beta-catenin. Curr Opin Genet Dev. 1999;9:15-21.
27. Kudo Y, Kitajima S, Ogawa I, Hiraoka M, Sargolzaei S, Keikhaee MR, Sato S, Miyauchi M, Takata T. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous betacatenin. Clin Cancer Res. 2004;10:5455-63.
28. Zhao X-J, Li H, Chen H, Liu Y-X, Zhang L-H, Liu S-X, Feng Q-L. Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: Relationships with prognosis. World J Gastroenterol. 2003;9:225-32.
29. Voutilainen KA, Anttila MA, Sillanpää SM, Ropponen KM, Saarikoski SV, Juhola MT, Kosma V-M. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer. J Clin Pathol. 2006;59:460-7.
30. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999;398: 422-6.
31. He T-C, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-12.
32. Fu L, Zhang C, Zhang L-Y, Dong S-S, Lu L-H, Chen J, Dai Y, Li Y, Kong KL, Kwong DL. Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/catenin signalling pathway. Gut 2011;60:1635-43.
33. Guturi KKN, Sarkar M, Bhowmik A, Das N, Ghosh MK. DEAD-box protein p68 is regulated by catenin/ transcription factor 4 to maintain a positive feedback loop in control of breast cancer progression. Breast Cancer Res. 2014;16:496-510.